| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Humans Matter [Automatic translation follows] International cognitive design company #paris #lyon #grenoble #toulouse #hongkong #newyork #philadelphia Humans Matter is a cognitive design company whose mission is to support the transition of behaviors in the environments of work, health, education and Society. Because the world suffers from its inability to act, Humans Matter innovates and designs solutions that act on the capacity to act and whose effectiveness is scientifically measured. Humans Matter acts on the capacity to act of individuals and collectives to: - Succeed in the various Transformations of companies - Increase the therapeutic effectiveness of a care pathway - Acquire the … Type: | 30 | 5 | 22 | 176 |
 | EV Biotech Accelerating Strain Development with smart use of models. EV Biotech is a microbial cell factory (MCF) strain development company. EV Biotech distinguishes itself by the use of state-of-the-art computational modelling. Using cutting-edge scientific developments in systems biology we create computational models of bacterial strains to predict most optimal strain modifications, growth media supplementation and scale up optimization in line with the rational design strategy. Fast-feedback loop between strain modellers and engineers increases development speed and efficiency of the MCF strain development pipeline. Preliminary models can be updated and enhanced quickly if needed, due to a close collaboration between a theoretical … Type: | 5 | 0 | 5 | 15 |
 | mbiomics GmbH Casting light on the microbiome We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life. microbiome, precision medicine, biotechnology, diagnostics, immuno-oncology, and companion diagnostics | 2 | 1 | 1 | 27 |
 | Lunaphore (a Bio-Techne brand) Accelerating Spatial Biology. Lunaphore Technologies S.A., a Bio-Techne brand, is a Swiss-based life sciences company founded in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. Community guidelines available here: https://link.lunaphore.com/guidelines Microfluidic technology, Immunohistochemistry, Cancer Research, Immuno-oncology research, Immunofluorescence, and Multiplex Type: | 4 | 3 | 0 | 158 |
 | GenoME Diagnostics Ltd Improving the ovarian cancer diagnostic pathway through earlier and more accurate diagnosis. GenoME Diagnostics is a spinout from the prestigious Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast. We are developing novel blood tests for earlier and more accurate detection of ovarian and pancreatic cancers. GenoME Diagnostics aims to reduce the misdiagnosis and late detection to improve patient survival and outcome. Our pipeline could be applied to biomarker discovery and development in a wide range of diseases and applications. | 0 | 0 | 0 | 5 |
 | Noema Pharma Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS | 1 | 1 | 0 | 31 |
 | Pludi EU #plant #biotech #verticalfarm Biotechnology research and development Type: | 0 | 0 | 0 | N/A |
 | Sensius Balanced Treatment Sensius is focused on establishing thermotherapy as a key treatment modality for cancer patients alongside radiotherapy, surgery, chemotherapy, and immunotherapy. Sensius mission is to deliver optimized radiotherapy treatment outcomes for patients with head and neck cancer, by balancing efficacy with quality of life. medical device, hyperthermia, oncology, head and neck cancer, and thermotherapy Type: | 1 | 0 | 0 | 10 |
 | Ascend Advanced Therapies Ascend is an advanced therapy development partner with a flexible platform featuring industry-leading analytics. Ascend is gene to GMP partner with deep expertise in advanced therapy development and commercialization. We offer unparalleled collaboration backed by expertise while working to develop your products from the bench through the clinic and beyond. Let’s build the future of advanced therapies together! Type: | 3 | 0 | 3 | 118 |
 | Rarity Bioscience Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation detection in liquid biopsy Rarity Bioscience provides ultra-sensitive multiplex assays for mutation detection in blood and other liquid biopsies for research, pharma and labs. The superRCA technology is based on padlock probes and rolling circle amplification, enabling extreme sensitivity and specificity, and utilize well established high throughput flow cytometry for the read-out. The company was founded in 2021 based on a discovery by Dr Lei Chen, PhD in molecular biology, and a member of Professor Ulf Landegrens team at the Department of Immunology, Genomics and Pathology at Uppsala … | 1 | 0 | 0 | 19 |
 | Nodus Oncology Developing next generation DDR targeting therapies Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response. Supported by most recent scientific advances, we are developing the next wave of cancer therapeutics in the DNA damage response (DDR) area. Founded by Cumulus Oncology and in partnership with the Lead discovery Center, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations Oncology Type: | 0 | 0 | 0 | 7 |
 | Valo Therapeutics Ltd Reinventing Cancer Immunotherapy Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea … Type: | 0 | 0 | 0 | 17 |
 | Telea Telea | An award-winning software that links Speech Therapists and their clients Telea | An award-winning software that links Speech Therapists and their clients to enable therapists to provide at-home speech therapy. Type: | 1 | 0 | 1 | 5 |
 | Recolony AG Harnessing the potential of the microbiome to cure cancer Cancer has emerged as a significant global public health concern, imposing a substantial and ever-increasing socioeconomic burden. The gut microbiota has been established as a critical component in regulating host immunomodulation, maintaining cancer immune homeostasis, and modulating the tumor microenvironment. Recolony is pioneering a groundbreaking approach to cancer treatment by harnessing the potential of the human microbiota. They have uncovered a specific mechanism, by which the gut microbiota activates the immune system, revealing a novel target for cancer immunotherapy. Through in-depth analysis of the host-microbiota interactions, they have identified a specific … Type: | 1 | 0 | 0 | 9 |
 |  NRG Therapeutics Mitochondrial therapeutics for the treatment of neurodegenerative diseases Type: | 5 | 0 | 5 | 12 |
 | TILT Biotherapeutics Ltd To make T-cells kill cancer, TILT is the answer TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his … Type: | 4 | 0 | 4 | 24 |
 | Droplet IV Medicine belongs in patients - not in the trash! 💧 Droplet IV is a need-driven MedTech start-up founded by doctors and engineers. Droplet started in the BioMedical Design Novo Nordisk Foundation Fellowship Programme and is currently in the Venture House incubator program at BioInnovation Institute. Problem: ≈20% of intravenous (IV) medicine is trapped as residual medicine in IV lines and never reaches the patient leading to significant underdosing. To mitigate this patient risk, nurses must spend an avg. of 2-3 minutes to flush each IV line manually. This is unrealistic and not scalable with the growing global nurse shortage. Solution: … Type: | 2 | 0 | 2 | 13 |
 | NeoDynamics Introducing NeoNavia® – The next generation of tissue sampling. NeoDynamics AB (publ) is a Swedish medical technology company dedicated to improving diagnostics and care to optimize individualized treatment in breast cancer. We are proud to introduce NeoNavia® - a modern biopsy system with patented pulse technology based on research from the Karolinska Institute in Sweden. The pulse biopsy system ensures optimal needle control with maximum tissue yield for any lesion type, size or location. For a reliable diagnosis and more prompt treatment. Type: | 0 | 0 | 0 | 14 |
 | FluoSphera The only company with a suite of systemic and high-throughput in vitro drug discovery solutions FluoSphera S.A. is the only company providing a suite of high-throughput, systemic, in vitro drug discovery solutions. Its proprietary chip-free platform uses flexible 3D cell systems that mimic the complex biology of the human body to rapidly and precisely study human response to systemic drug delivery. FluoSphera offers four distinct drug discovery solutions: (1) multiplexing for target selectivity, (2) measuring systemic efficacy and toxicity, (3) systemic biomarker identification, and (4) translational species optimization. Type: | 6 | 0 | 6 | 4 |
 | Reshape Biotech Accelerating the pace of R&D. Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing … Type: | 3 | 2 | 1 | 56 |
 | Resalis Therapeutics Tackling metabolic disorders with non-coding RNAs Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders. Type: | 0 | 0 | 0 | 9 |
 | Evonetix Ltd Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio Type: | 3 | 0 | 3 | 32 |
 | Hemab Therapeutics The next generation of therapeutics for bleeding and thrombotic disorders Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious … Type: | 1 | 0 | 1 | 49 |
 | Tetra Pharm Technologies We do science Tetra Pharm is a research focused biopharmaceutical company. Type: | 2 | 0 | 2 | 43 |
 | AI Medical Technology Developing AI powered diagnostic solutions enabling healthcare providers to make faster and more reliable diagnoses. We are dedicated to developing AI powered diagnostic solutions that enable frontline healthcare practitioners to make easier, faster and more reliable diagnoses for their patients. Our first product, Dermalyser, is undergoing clinical validation as a decision support tool for the diagnosis of all skin cancers. skin cancer and AI Diagnostics Type: | 1 | 0 | 0 | 13 |
 | Machine Bio Machine Bio is a biotech company offering unique protein synthesis and purification solutions. Machine Bio is an early stage biotechnology company developing a novel, proprietary protein synthesis platform that can produce pure protein from a DNA template in a easy-to-use, single-step, 4 hour process. Proteins are broadly used in many industries and Machine Bio’s platform has a range of possible applications across drug discovery and development, synthetic biology research, industrial enzyme optimization, and commercial therapeutic manufacturing. Protein Synthesis, Protein Purification, Contract Protein Expression, R&D, Startup, Cell-Free Systems, and Supported Lipid Bilayer Type: | 1 | 1 | 0 | 3 |
 | ExeVir Rapid Viral control in a world that needs it Exevir Bio is a biotech company developing efficacious heavy chain-only antibodies to prevent and treat infectious diseases and make a difference in pandemic preparedness. The technology platform of ExeVir uses humanized camelid heavy chain-only antibody fragments (VHH) fused to a human IgG Fc to create new therapeutic compounds. ExeVir is building a strong pipeline of antibody therapies with an initial focus on COVID-19 and dengue. Compared to conventional monoclonal antibodies, the modular VHH building blocks provide a unique combinatory flexibility. In addition, the design of multi-specific constructs is substantially simplified. VHHs … Type: | 3 | 0 | 2 | 20 |
 | DeuterOncology NV Developing deuterated BEST in CLASS MET kinase Inhibitor DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2. Drug Development, Deuterated small molecules, and MET kinase inhibitor Type: | 0 | 0 | 0 | 5 |
 | Rewind Therapeutics Rewind Therapeutics is developing first-in-class remyelinating therapies for myelin-related diseases and aims to bring them into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition and movement, among others. The causes of damage may be genetic, a result of infectious or autoimmune disease or from exposure to toxic agents or other forms of brain injury. There is no cure for demyelinating diseases. The Company was founded by KU Leuven’s Centre for Drug Design and Discovery (CD3) and … Type: | 0 | 0 | 0 | 20 |
 | NeoPhore Ltd Discovering drugs that create neoantigens NeoPhore, UK is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. Generation of cancer neoantigens in tumours can be exploited by the patients’ immune system to overcome natural defence mechanisms in cancer. The Company’s approach targets the DNA mismatch repair (MMR) pathway, which has been proven to promote neoantigen creation and subsequent immunity against numerous cancers. Using these insights, NeoPhore aims to generate next-generation immuno-oncology therapeutics to improve clinical outcomes for cancer patients. NeoPhore was spun-out of the University of Turin and PhoreMost … Type: | 1 | 0 | 1 | 17 |
 | Refined Laser Systems GmbH Label-free and chemically specific imaging for life science and medical diagnostics Refined is a young biophotonics company from Münster, Germany, aiming to transform the treatment of cancer. During today's cancer treatments, surgeries must be repeated in up to one third of all cases because it remains a challenge to quickly identify cancer cells without extensive biopsy processing. With its pioneering laser technology, combined with advanced microscopy methods and artificial intelligence, Refined has stepped up to empower surgeons and pathologists to overcome this challenge. fiber laser, picosecond laser, 2-photon microscopy, and microscopy Type: | 2 | 0 | 2 | 14 |
 | Humane Genomics Platform to engineer cancer killing viruses using synthetic biology. Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21) Type: | 5 | 1 | 5 | 5 |
 |  VUS Diagnostics VUS Diagnostics is a company that understand the functional impact of gene variants in genetic disease including cancers. | 0 | 0 | 0 | N/A |
 | Actipulse Neuroscience® Neuromodulation therapeutics from the hospital, directly to the home of the patient. A Paris Brain Institute company. Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Neuromodulation, Depression, Alzheimer's, and Neurotech Type: | 5 | 4 | 0 | 38 |
 | Monument Therapeutics Bringing Precision Medicine to Neuroscience Drug Development Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience … Type: | 0 | 0 | 0 | 6 |
 | CELLUGY® Creating sustainable materials to replace fossil based material/polymer through biofabrication! We are a Danish biotech startup based in Søborg, with global ambition. We created superior material from nature's most abundant building block, cellulose. biodegradable material, sustainable material, plastic replacement, environmental packaging, green technology, biotechnology, personal care, textiles, cellulose, personal care products, and cosmetics Type: | 7 | 3 | 0 | 22 |
 | YD Pharmaceuticals Patient focus YD Pharmaceuticals is a pharmaceutical company, with an EU-GMP certified indoor facility producing medical cannabis and distributing to EU Countries and other markets. With a 5,000m2 state of the art indoor facility located near Porto, YD Pharmaceuticals is strategically positioned to meet patient needs across all markets. Quality, stability, transparency and patient focus are YD Pharmaceuticals core values. | 0 | 0 | 0 | 1 |
 | Tandem Therapeutics Unlocking the matrix barrier to treat fibrotic diseases TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases. Type: | 0 | 0 | 0 | 5 |
 | Allegria Therapeutics Mastering Mast Cells Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases. For more information, please visit www.allegriatx.com Mast Cell-Targeted Therapeutics, Allergy, and Inflammatory Disease Type: | 0 | 0 | 0 | 2 |
 | Metsystem Personalized cancer patient treatment that targets metastasis. Personalized cancer patient treatment that targets metastasis. We can treat preventatively and create better patient outcome. Metsystem is developing a metastasis-targeting drug screen platform that is capable of predicting the most effective drug for each patient. With an accurate drug screen we can guide treatment and create better patient outcomes. Type: | 3 | 1 | 2 | 19 |
 | Cellsway Cellsway is a fresh deep-tech start-up founded in March 2020 in UK to convert the know-how and cutting-edge core technology that have been developed and cultivated at Mikro Biyosistemler Inc. into commercial products to set the gold standard for diagnosis and management of cancer. The flagship product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells (CTCs) from the blood samples of cancer patients. Type: | 4 | 0 | 0 | 6 |
 | TrackPaw Scientific AB We digitalise preclinical studies to increase welfare and research quality. TrackPaw Scientific's deep tech solution for 24/7 monitoring of early stage pharmaceutical development offers improved animal welfare together with better study outcomes. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R Type: | 1 | 0 | 1 | 10 |
 | Synerkine Pharma Creating Innovative Pain Solutions Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands. Type: | 1 | 0 | 1 | 8 |
 | Egetis Therapeutics AB Pharmaceutical drug development company, focusing on late-stage development for treatment of serious rare diseases. Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment Type: | 0 | 0 | 0 | 47 |
 | Bentley Development & manufacture of innovative endovascular products for the treatment of peripheral vascular & aortic disease. Bentley’s passion is the development, manufacturing and marketing of innovative implants for minimal-invasive treatments of vascular diseases. Bentley was founded in 2009 by medical entrepreneurs Lars Sunnanväder and Miko Obradovic. The company has seen substantial growth since the launch of its first product in 2012. Since then Bentley rapidly expanded worldwide. Thanks to its international network of exclusive distribution partners Bentley is represented in more than 80 countries – in some even as market leader. Bentley is the only company worldwide that offers a … Type: | 2 | 0 | 2 | 244 |
 | Cirdan Ltd Leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients. Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Our systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. The company was founded in 2010 and is headquartered … Type: | 3 | 0 | 2 | 103 |
 | ARTICA Therapeutics Development of covalent small molecules to transform the treatment of autoimmune and inflammatory disorders ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need. Type: | 1 | 0 | 0 | 17 |
 | RoukenBio We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward. RoukenBio – CRO redefined. RoukenBio takes its tagline seriously - disrupting the traditional CRO model with a collaborative, personalised approach to drug discovery. With customers in over 27 countries, RoukenBio aims to become the most trusted research partner to biotherapeutic innovators globally. Backed by brilliant minds, RoukenBio offers a range of in vitro drug discovery services with specialist expertise across human immunology, bioanalytical, cell line engineering, molecular biology, bioassay development and safety and efficacy assessments. RoukenBio partners with therapeutic developers from early … Type: | 0 | 0 | 0 | 84 |
 | Onena Medicines AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed … Type: | 0 | 0 | 0 | 13 |
 | ADOR Diagnostics Molecular Diagnostics Innovations ADOR Diagnostics is an innovative IVD company that specializes in the development of cutting-edge syndromic multiplex molecular biology diagnostics technology. ADOR sets a new standard by revolutionizing the way laboratories worldwide diagnose infectious diseases with multiplex,sample-to-answer, fully automated systems that deliver accurate results rapidly. By using ADOR’s systems, laboratories can reduce costs and increase efficiency while doctors are able to treat patients with confidence, knowing they would prescribe the correct antibiotics and the right treatment. The NATlab system is a multiplex isothermal (RCA) based cutting-edge molecular biology platform with a bench-top modular analyzer and a disposable all-included … Type: | 0 | 0 | 0 | 16 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry Type: | 0 | 0 | 0 | 17 |
 | Pixelgen Technologies Pioneering Spatial Proteomics for Single Cells Pixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by developing tools to facilitate the mapping of cell surface proteins and their spatial inter-relationships. Life operates by the spatial orchestration of proteins and at Pixelgen we have developed Molecular Pixelation that analyses cell surface proteins in a completely new way. Using current technologies, there are limitations of light and taking images influencing how many proteins and how many samples that can be analysed concurrently. With molecular … Type: | 0 | 0 | 0 | 29 |
 | LimmaTech Biologics AG Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, biotechnology, and antimicrobial resistance Type: | 1 | 1 | 0 | 46 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 14 |
 | Double Bond Pharmaceutical International AB Double Bond Pharmaceutical is a fast growing pharmaceutical company that develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company is to provide patients and the market with more efficient and safe products especially in areas where these needs are unmet. The human population is growing and also the life-span is increasing. Many children born today can be expected to live until they are about 100 years old. By these reasons it can be expected that the need for efficient therapies for treatment of different diseases will … Type: | 0 | 0 | 0 | 14 |
 | Blue Scientific Ltd. Distributor of market-leading scientific instruments for microscopy & materials science in the UK & Nordic region. Blue Scientific provides market-leading scientific instruments for materials science research and microscopy in the UK and Nordic region. UK and Irish distributor for: - Bruker - Micro-CT (X-ray microscopy), TXRF trace element analysis and micro-XRF elemental analysis. - CAMECA - Elemental and isotopic analysis. - Thermo Scientific - ChemiSEM SEM/EDS Nordic region (Norway, Denmark, Sweden, Finland, Iceland): - Bruker Nano Surface Analysis - AFM, 3D optical microscopes, stylus profilers, tribology and mechanical testing - Bruker - Micro-XRF elemental analysis, TXRF, Micro-CT and X-Ray analysis … Type: | 2 | 1 | 2 | 23 |
 | Predictiv Care 🧬 DNA-based Digital Twin to help predict and prevent diseases and adverse reaction to drugs Personal genomics solution for predictive medicine—Thanks to unique and groundbreaking technology, Predictiv identifies the genetic predispositions of an individual on 22,000+ diseases and simulated reactions to 750+ drugs. Now enabling more accurate preventive actions and treatments. genomics, predictive medicine, preventive medicine, heathcare, and biotechnology Type: | 18 | 3 | 14 | 11 |
 | Age Labs AS Extending human healthspan Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead. However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice. But how do we know these treatments will work in humans? We can wait and see if patients receiving … Type: | 0 | 0 | 0 | 4 |
 | 1928 Diagnostics Where complex data turns into actionable results. 1928 Diagnostics offers a bioinformatics analytics platform for infection control. Using sequence data, 1928 contributes to the fight against infections by identifying and characterizing pathogens to assist in tracking, controlling, and preventing outbreaks. Our innovation offers a solution to control the spread of infections and save the power of antibiotics, thereby improving world health and saving costs for healthcare systems. bioinformatics, software, antibiotic resistance, infection diagnostics, microbiology, MRSA, next generation sequencing, whole genome sequencing, outbreak surveillance, software-as-a-service, clinical bacteriology, molecular biology, and genomics Type: | 3 | 2 | 1 | 15 |
 | Sigrid Therapeutics 100% Natural Stability For Your Blood Sugar Levels and Weight With science-backed, 100% natural solutions, we empower journeys toward balanced and healthier lives by optimizing metabolism and making well-being achievable every day. prediabetes, diabetes, blood sugar management, healthtech, obesity, innovation, medical device, biotech, and life science Type: | 2 | 1 | 2 | 19 |
 | Carbiotix Pioneering onsite upcycling of plant-based side-streams Carbiotix is an award-winning biotechnology company pioneering the onsite upcycling of plant-based side-streams. Carbiotix mission is to improve the health of people by increasing the consumption of prebiotics and other active ingredients from upcycled side-streams. Carbiotix offers one core service today called NutraCycle, an on-site upcycling and fortification service allowing food & beverage, ingredient, and feed producers to turn plant-based products into healthier, more profitable, and sustainable products. Gut Health, Microbiome, Prebiotics, Upcycling, Plant-based, Food & Beverage, Ingredient, Feed, Biotechnology, Process Engineering, Product Design, Active Ingredients, and Onsite Type: | 0 | 0 | 0 | 17 |
 | Samsara Therapeutics Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development Type: | 1 | 0 | 1 | 20 |
 | SENISCA Applying world-leading molecular genetics to solve the diseases and aesthetic signs of ageing SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics). Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells. At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new … Type: | 1 | 0 | 1 | 23 |
 | Life Length Measuring life for the world Founded in 2010, Life Length stands out as a global leader in diagnostic biotechnology, specializing in telomere diagnostics. Our proprietary platform technology, TAT®, is based on the measurement of telomere variables and assays related to aging and age-related diseases. This patented technique allows quantification of telomere length at the individual cell level and is applicable to blood, cell culture and tissue samples. Recently, we have developed a biomarker for the early detection of prostate cancer with this technology. This biomarker is authorized by the AEMPS in Europe and by the CMS in the United States, … Type: | 2 | 1 | 2 | 50 |
 | enginzyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … Type: | 8 | 3 | 6 | 46 |
 | Uncommon We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering. Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the … Type: | 9 | 2 | 5 | 61 |
 | Baseimmune A data-driven platform specialised in pathogen analysis for antigen discovery and vaccine design Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field. Vaccines Type: | 3 | 2 | 1 | 23 |
 | Equinom Ltd Cultivating food that's better for people and our planet Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise and deep technology to develop delicious, nutritious, affordable and sustainable non-GMO plant-based ingredients – from the ground up. Sustainable, plant-based proteins are key to feeding Earth’s 10B people by 2050 The plant-based food market grew 27% in 2020 and is projected to reach $162B by 2030. The industry is unable to supply the full demand for food vs. feed For decades, crops have been farmed primarily for animal feed – not for human consumption. To be palatable in human … Type: | 4 | 0 | 4 | 26 |
 | Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy Type: | 4 | 1 | 2 | 32 |
 | Data&Data - The intelligence of luxury Empowering brands with AI to curb the online grey market, capture resale trends, and attain competitive intelligence Founded in 2012, Data&Data is specialised in the luxury sector from watches and leather goods to fragrances. We help key decision makers to understand the ever-changing dynamics of the global online market. This enables them to make more informed and effective strategies. Data&Data is a privately held company, headquartered in Paris, France. Take a look at our blog on medium.com/@DATAANDDATA Big data, Analytics, Consulting, Data Management, Innovation, Information Management, Data science, Statistics, Datamining, Predictive analysis, Ecommerce Counterfeit Detection, Business intelligence, Artificial intelligence, Luxury, … Type: | 8 | 2 | 6 | 10 |
 | GlioCure A preclinical-stage drug-development company specialized in neuro-oncology GlioCure, a spin-off company of Angers and McGill Montreal universities, aims to treat glioblastoma that causes 200,000 deaths worldwide each year. To overcome this challenge, GlioCure is hyper-specialized and develops glioblastoma-specific drugs. GlioCure is currently focusing on the development of GC01, an anti-glioblastoma peptide discovered by Joël Eyer, Director of Research from INSERM, and covered by two patent families for which GlioCure owns worldwide exclusive rights. GlioCure's team has the experience and the know-how to ensure the successful completion of GC01’s development plan: Louis-Marie is a biotech entrepreneur with 15 years of experience … Type: | 12 | 7 | 7 | 5 |
 | iligo Agence d'études et de conseils en marketing iligo is an award-winning research agency and consultancy focused on understanding new consumer behaviors and assessing the effectiveness of marketing activities for brand building. iligo clients include multi-national advertisers, media companies and advertising agencies. We leverage cutting-edge technologies and innovative techniques in data collection and analyses. Check out our work at www.iligo.fr. Specialties marketing communications research, passive advertising effectiveness measurement, cross-platform advertising assessment, mobile research, digital out-of-home research, neuroscience, econometrics marketing, communication, etudes, consommateurs, mesure passive de l'efficacité publicitaire, exposition publicitaire cross-plateforme, études digital out of home, neuroscience, économétrie, études mobiles, émotions, études … Type: | 5 | 3 | 0 | 12 |
 | FLUOPTICS Part of Getinge Fluoptics is a young and innovative company in the field of fluorescence imaging for both clinical and preclinical applications. In clinics, Fluoptics develops solutions to optically guide cancer surgery. This approach is based on an intra-operative near infra-red fluorescence detector and fluorescent probes which specifically target tumors. This technology, extensively tested on animals, drastically improves cancer surgery in providing surgeons with an acute delineation of cancerous nodules during the surgery. Fluoptics develops and markets the Fluobeam, a unique fluorescence imaging system with an open design and an excellent sensitivity in the near infra-red spectrum. The company also proposes near infra-red … | 5 | 6 | 1 | 29 |
 | Cherry Biotech Alternative to Animal Testing for Drug Development Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert … Type: | 3 | 2 | 0 | 23 |
 | nextProtein Feeding the future. The world’s population is estimated to reach more than nine billion by 2050. Global food production will have to increase by 70 per cent to feed everyone. Meanwhile one third of all food produced is wasted. At nextProtein we’re driven by a personal desire to address land and resource scarcity and feed a rising population sustainably. nextProtein can produce the equivalent amount of protein from 100sqm as 100ha of soya field. Founded by couple Syrine Chaalala and Mohamed Gastli, we produce insect-based protein for animal feedstocks with a negligible carbon footprint, at a lower cost and with … Type: | 16 | 3 | 7 | 50 |
 | Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: | 10 | 7 | 3 | 22 |
 | FERMENTALG [Automatic translation follows] ALGAE, YOU CAN TRUST About Fermentalg: Based in Libourne (France), Fermentalg is an industrial biotechnology company, specialized in the production of oil rich in fatty acids (omega-3), proteins and natural pigments (phycocyanin) by fermentation of microalgae. Fermentalg offers innovative products in the global market such as Food, Feed and Environment. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, www.fermentalg.com About Fermentalg: Based in Libourne (France), Fermentalg is an industrial biotechnology company, specialized in the production of oil rich in fatty acids (omega-3), proteins and natural pigments (phycocyanin) by fermentation of microalgae. … Type: | 17 | 9 | 8 | 90 |
 | Bioxis Pharmaceuticals #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid Type: | 0 | 0 | 0 | 28 |
 | Eligo Bioscience Precision medicines for the microbiome Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. | 19 | 12 | 4 | 43 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 14 | 11 | 6 | 34 |
 | lifeina Creators of the world's smallest fridge, designed to keep your medication at a constant temperature wherever you may go. Our future is one in which the lives of medication users are not dictated by their health. A future where you have the freedom to take control by using the right tools. ___ Without flawless execution, ingenious ideas might as well remain dreams. We honour our reputation and strive to be industry leaders. In doing so, we keep our small team flexible enough to listen and respond to your needs directly. So, when you speak to one of us, you’re speaking … Type: | 5 | 4 | 0 | 7 |
 | Insight Biosolutions Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK Type: | 3 | 2 | 0 | 4 |
 | Origem Sustainable Sourcing Fulfill companies’ sourcing ambitions by bringing them closer to sustainable solutions Origem guides your company implementing a sustainable sourcing strategy. Today, having a sustainable and traceable sourcing strategy is both a strength and a competitive advantage. Tomorrow, it will be the norm: requirements related to traceability and social and environmental production conditions of raw materials will be as important as quality and prices. Origem wants to embody the companies’ shift towards models that will transcend Human and Nature’s strength At Origem ... • We look for exemplary raw materials; whether mineral, plant or animal • We identify and connect the … Type: | 9 | 1 | 8 | 4 |
 | Manzalab DIGITAL EXPERIENCING PIONEER Manzalab Group is a digital experiences designer. Since 2010, we use neuroscience research scientific rigor and technological developments to serve all sorts of creativity. With offices in Paris, Aix-en-Provence and Singapore, our ecosystem comprises six entities, six different but complementary excellence centers: Manzalab, Manzavision, Akenomy, Perfect Industry, CyberZen and Longue-Vue. Together, we create new digital experiences covering several different areas such as: training, communication, design, industry, cyber-security and entertainment. At the forefront of Collaborative VR, we design our experiences for PCs, tablets and mobile phones as well as for virtual and augmented reality environments. Our skills The … Type: | 18 | 4 | 14 | 27 |
 | My Intelligent Machines Inc. MIMs helps life scientists harness the power of human & AI to push the boundaries of drug development Montreal-based My Intelligent Machines (MIMs) is a leader in artificial intelligence and systems biology. MIMs provides Biopharma companies with easy-to-implement and interactive augmented intelligence systems, allowing for accurate biological simulations at the early drug development stage, to assist life scientists in the development of precisely targeted and personalized therapies. MIMs markets augmented intelligence systems packaged in a software-as-a-service (SaaS) solution, to support patient stratification and the selection of therapeutic targets and biomarkers, both required for the development of more efficient and personalized … Type: | 7 | 2 | 0 | 3 |
 | ENDODIAG Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients worldwide!). Located in Evry, France, within Genopole, the French largest Biocluster, the company leverages the experience of its scientific cofounders who have been working in this field for over 20 years and a network of major hospital centres both in France and abroad. Although endometriosis is a major cause of subfertility (40% of affected patients are infertile) and chronic pain, it takes … Type: | 8 | 6 | 0 | 6 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 16 | 31 | 182 |
 | PathoQuest A global CRO providing NGS-based Quality Control testing for rapid and safe release of biotherapies to patients. PathoQuest is a global CRO providing NGS-based Quality Control testing through its iDTECT® platform of assays for rapid and safe release of biotherapies to patients. Validated and accepted GMP assays for viral safety and genetic characterization of raw materials, cell and gene therapies, mAbs & vaccines. Testing available in Paris (France) and in Wayne PA. Biologics Testing, Biosafety Testing, Biologics Quality Testing, Biologics QC based on Next Generation Sequencing (NGS), Viral Safety, Genetic Characterization, Testing for Clone selection, Genetic Stability Testing, Release Testing … Type: | 1 | 0 | 1 | 55 |
 | Conscious Labs Think Beyond • Conscious Labs is a Deep Tech company in the field of Neuroscience & Neurotechnology. • Conscious Labs develops innovative global solutions (hardware and software) for brain-computer interfaces or BCI (Brain Computer Interfaces) based on EEG (ElectroEncephaloGraphy). • Presented as a new generation Neuroheadsets (portable, wireless and equipped with patented ThinkPulse neurosensors), our EEG devices are aimed at research, development and experimentation, and are particularly suited to the sectors of: Aerospace, Automotive, Transport, Defense, Security, Health, Education and Research or Sport for example. • Designed by our team, the ThinkPulse polymeric neurosensor represents a true technological breakthrough with … Type: | 3 | 2 | 0 | 8 |
 | POLYVALAN Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design Type: | 2 | 1 | 0 | 3 |
 | Qfluidics Innovation using ferrofluids Our liquid tube technology is born from the french public efforts from the university of Strasbourg and allows us to transport liquids... using liquids thus opening new prospects in continuous flow manufacturing of chemicals where solids (catalysts or crystals formed in situ) tend to clog the channels of continuous flow reactors leading in periods of production standstill. Qfluidics has developed the very first non-clogging continuous flow reactor to perfectly handle any type of solids, thus paving a new avenue towards sustainable continuous flow chemistry. Type: | 8 | 5 | 5 | 12 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 36 | 14 | 31 | 82 |
 | ABIONYX Pharma A New Generation Biotech Company ABIONYX Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. | 2 | 1 | 1 | 8 |
 | Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 15 | 9 | 6 | 77 |
 | Stimunity Turn cancer immunotherapies active in most patient Stimunity is a startup company from Institut Curie which develops bio-pharmaceuticals to treat patients that do not respond to immunotherapy in cancer. | 3 | 2 | 0 | 5 |
 | Alara group A complete radiation expertise in one group Physics and biology at the service of medicine and radiation-related risk management for patients and workers. ALARA Group is an active holding company gathering all supports functions from 4 cutting-edge companies: • ALARA Expertise, medical physics and radioprotection specialist • Fibermetrix, developing services and dosimetry products in complex environments • Spin Up, specialized in Magnetic Resonance Imaging as well as patients and workers electromagnetic field safety • Neolys Diagnostics, developing predictive, patient-specific radiosensitivity tests allowing for personalized radiotherapy treatments. Are you working in a medical imaging center using X-rays or MRI, in a … Type: | 9 | 4 | 7 | 30 |
 | DIABNEXT Hassle-free Diabetes Life - Digital management solution DIABNEXT was founded with the vision of developing highly innovative solutions that help people with diabetes better manage their chronic condition and improve their care and quality of life. Through collaboration with many leaders and clinicians in diabetes healthcare, the DIABNEXT platform offers patients a unique solution that enables remote monitoring, coordination, therapeutic education and analytics of data related to blood glucose, insulin, diet and physical activity automatically through connected health devices. DIABNEXT was acquired by Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic … Type: | 10 | 8 | 2 | 3 |
 | TINCTURA [Automatic translation follows] Manufacturer ǀ Manufacturer of food supplements and beverages ǀ Nutraceutical ǀ Liquid extracts ǀ Plant extracts Tinctura was born from a desire: to make active molecules present in nature, recognized for their health benefits, accessible to all in liquid form. Based in Brittany since its creation in 2018, the company offers a wide range of products: extracts based on plants, algae or objectified ingredients (extracts claiming at least one health claim, or having been the subject of published scientific or clinical studies) as an ingredient for your formulas or in food supplements in your image. From the … Type: | 7 | 3 | 5 | 3 |
 | Voxcan Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and … Type: | 6 | 1 | 5 | 16 |
 | Labovet Produtos Veterinários [Automatic translation follows] For over 30 years, we have been a reference in the production of vaccines and veterinary products. We are proud to be 100% Brazilian. Labovet is a pharmaceutical company that offers medicines and vaccines for small, medium and large animals. For over 30 years, our focus has been on animal health, through products with high quality standards and constant investments in research and modernization of our factory. We operate throughout Brazil with distribution centers in strategic locations in the country, in order to have the best delivery conditions and guarantee the proper packaging of our products. Biologicals, … Type: | 0 | 0 | 0 | 181 |
SMB